Japanese Inspection Finds More Tainted Blood Products (Japan)
This article was originally published in PharmAsia News
Another tainted blood product has been discovered in Japan, this one extending back to the 1970s and children exposed while being treated for measles and other common diseases. The hepatitis C virus was discovered in samples of immunoglobulin preparations produced in 1977 by Green Cross, which became part of Mitsubishi Tanabe Pharma. Two samples stored since then were found to contain the virus. The supply was never tested for the disease in Japan until 1989, when the preparations were used to prevent coronary artery aneurysm in children with Kawasaki disease. (Click here for more
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.